Display Settings:

Format

Send to:

Choose Destination
    Rheumatol Int. 2011 Apr;31(4):533-5. Epub 2009 Oct 23.

    Anaplastic large cell lymphoma in a patient with rheumatoid arthritis.

    Source

    Department of Rheumatology, Abant Izzet Baysal University Medical Faculty, Bolu, Turkey. cemalbes@hotmail.com

    Abstract

    It is known that patients with rheumatoid arthritis (RA) have an increased risk for non-Hodgkin's lymphomas in comparison with the general population. Although increased risk of lymphoma is attributed to the disease activity, the drugs used in the therapy of RA may also cause increased risk of malignancy. Herein, we report on an RA patient who developed non-Hodgkin's lymphoma after methotrexate therapy and review the literature about it. A 74-year-old man with RA had been treated with low-dose methotrexate and subsequently developed anaplastic large cell lymphoma of the T-cell phenotype. Anaplastic large cell lymphoma has been reported rarely in rheumatoid arthritis.

    PMID:
    19851770
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk